Tiny implant shows promise for glaucoma control during cataract surgery

NCT ID NCT05062668

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether placing a tiny device called iStent during cataract surgery helps lower eye pressure in people with primary open-angle glaucoma. Researchers compared 80 patients who got the implant plus cataract surgery to those who had cataract surgery alone. The goal was to see if the implant safely improves pressure control over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

iStent inject or inject W implant

What this could lead to

If successful, this could offer a safer way to lower eye pressure in glaucoma patients during cataract surgery, reducing the need for eye drops or more invasive surgery.

What could go wrong

This is a small, completed observational study, not a large randomized trial. The implant may not lower pressure enough for all patients, and long-term benefits or risks are not fully known.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens Nord

    Amiens, 80054, France